Matches in Wikidata for { <http://www.wikidata.org/entity/Q65474790> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q65474790 description "assaig clínic" @default.
- Q65474790 description "clinical trial" @default.
- Q65474790 description "clinical trial" @default.
- Q65474790 description "clinical trial" @default.
- Q65474790 description "clinical trial" @default.
- Q65474790 description "ensaio clínico" @default.
- Q65474790 description "ensayo clínico" @default.
- Q65474790 description "ensayu clínicu" @default.
- Q65474790 description "essai clinique" @default.
- Q65474790 description "klinisch onderzoek" @default.
- Q65474790 description "клінічне випробування" @default.
- Q65474790 name "Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)" @default.
- Q65474790 name "Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC" @default.
- Q65474790 type Item @default.
- Q65474790 label "Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)" @default.
- Q65474790 label "Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC" @default.
- Q65474790 prefLabel "Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer)" @default.
- Q65474790 prefLabel "Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC" @default.
- Q65474790 P1132 Q65474790-B8667209-FD03-4640-A921-F889A99B4F42 @default.
- Q65474790 P1476 Q65474790-8FDCA111-D36C-4DC8-A837-496990D5A63C @default.
- Q65474790 P17 Q65474790-261D817A-3912-44A2-AC58-9B479B9A3BA6 @default.
- Q65474790 P17 Q65474790-48AE71FC-4331-421F-8C7E-096DA1E3B75D @default.
- Q65474790 P17 Q65474790-625778B2-5DDB-455C-93E1-DE573F6D05BB @default.
- Q65474790 P17 Q65474790-7EB5B852-5A13-4812-9180-1F2CE50F158B @default.
- Q65474790 P17 Q65474790-9D7CDC92-9D3F-429E-BDBA-C06B7704B713 @default.
- Q65474790 P17 Q65474790-9F6C9A63-5F76-4221-BC13-34703DA10847 @default.
- Q65474790 P17 Q65474790-A9B50690-319A-4711-889A-8BF85B8557AE @default.
- Q65474790 P17 Q65474790-B8B2B249-E0D2-43A6-93E6-F9F0B8B10044 @default.
- Q65474790 P2899 Q65474790-AEDF457A-1FFB-4D02-999F-477713008EDC @default.
- Q65474790 P3098 Q65474790-D7CBD875-30C6-4C33-AC2C-FEF33AC84D16 @default.
- Q65474790 P31 Q65474790-803869B2-AAF5-4A9B-B558-0CAD188C914A @default.
- Q65474790 P580 Q65474790-C487765E-25F9-49E3-87AC-9501E2CF1491 @default.
- Q65474790 P582 Q65474790-152D6E36-E69B-49D5-82D9-74D8E37D0EE0 @default.
- Q65474790 P6099 Q65474790-F3F53021-B504-42A1-951F-57964AB4006D @default.
- Q65474790 P8363 Q65474790-1D49CF0A-7BAB-42B0-B1CD-35935BBF7FE8 @default.
- Q65474790 P859 Q65474790-40ACEC13-6009-4F21-A8BC-BEFD90557090 @default.
- Q65474790 P1132 "+186" @default.
- Q65474790 P1476 "A Three Cohort Phase II Trial of BMS-275183 Given Orally on a Twice Weekly Schedule in Pretreated Locally Advanced or Metastatic NSCLC Patients" @default.
- Q65474790 P17 Q142 @default.
- Q65474790 P17 Q145 @default.
- Q65474790 P17 Q16 @default.
- Q65474790 P17 Q29 @default.
- Q65474790 P17 Q30 @default.
- Q65474790 P17 Q31 @default.
- Q65474790 P17 Q38 @default.
- Q65474790 P17 Q55 @default.
- Q65474790 P2899 "+18" @default.
- Q65474790 P3098 "NCT00359450" @default.
- Q65474790 P31 Q30612 @default.
- Q65474790 P580 "2006-07-01T00:00:00Z" @default.
- Q65474790 P582 "2007-03-01T00:00:00Z" @default.
- Q65474790 P6099 Q42824440 @default.
- Q65474790 P8363 Q78089383 @default.
- Q65474790 P859 Q266423 @default.